You searched for "consent"

3223 results found

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Home Wi-Fi / range and security tips

This issue covers two topics that relate to Wi-Fi. The first is keeping your wireless network secure and the second is extending its range. Keeping home Wi-Fi secure Let’s say the recent computer attacks that resulted in disruption to NHS...

The Duke-Elder exam: A medical student’s head start into ophthalmology

The Duke-Elder exam is a specialist ophthalmology exam intended for medical students to sit during medical school. It is named after Sir Stewart Duke-Elder, a pioneering Scottish ophthalmologist who was active in the first half of the 20th Century by...

Use of off-the-shelf magnifying glasses as a cost-effective alternative for surgical loupes

Surgical loupes are an integral part of ophthalmic surgery on the ocular surface and in the periocular area. Available in different magnifications, they provide a clear view of the field of surgery which can greatly assist in identifying fine structures...

Comic leaflets: an innovative method of patient education

Nowadays almost everyone has been exposed to comics, especially during childhood. In a way, this is a natural form of progression from children’s story books, which also contain words and pictures. This exposure has helped us to develop the graphic...

Inherited retinal disorders now the leading cause of blindness

The recent paper in BMJ Open, from the UCL Institute of Ophthalmology, ‘A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010’ concludes that inherited retinal disorders (IRD) such...

The last three patients: general medicine (Patient Two)

For the second reflection in this series (see Patient One here), Professor Jonathan Rees recounts his experiences of the last patient he saw as a medical registrar, telling the tragic story of a young man’s death and the risks that...

Patients use their own blood to treat dry eye symptoms

Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’? Headline: Patients use their own blood to treat dry eye symptoms Grossman first described the technique of...

Optic nerve swelling – your survival guide (part 2)

In this second article we will discuss bilateral optic nerve swelling, its aetiology, various investigations and possible treatments. We will also discuss various protocols used in the management of suspected optic nerve swelling cases. (Part one of this topic available...

Neovascular AMD: fresh recommendations underline standards of best practice

The management of neovascular age-related macular degeneration (nAMD) has advanced dramatically over the past seven years, with the introduction of targeted new therapies that successfully maintain or improve vision in a majority of affected individuals. It’s a fast moving field,...

A Nightmare on Doctor Street

“Number one: you can never have sex. Big no no! Big no no! Sex equals death, okay?Number two: you can never drink or do drugs. The sin factor! It’s a sin. It’s an extension of number one.And number three: never,...

OSA Insights to Market win praise from members

OSA members praised the breadth of optical market insights provided by the Autumn meeting this week as a broad spectrum of suppliers gathered in London, reinforcing the strength of the trade body.